Maximize Your Impact at Pharma R&D 2026
Pharma R&D 2026, scheduled for March 9 at the Four Points by Sheraton Wakefield Boston Hotel & Conference Center in Boston, Massachusetts, brings together senior professionals across biopharma R&D, clinical development, and regulatory strategy. The event serves as an important forum for decision-makers overseeing research pipelines, partnerships, and technology integrations that shape the next phase of drug development.
Attendees range from heads of R&D, clinical trial executives, and innovation leads to external collaboration directors seeking new platforms and partners. With budgets, licensing opportunities, and digital investments on the table, early visibility into who’s attending creates a significant advantage.
Access to Vendelux’s enriched attendee list allows commercial and business development teams to prioritize outreach based on role, organization type, and current initiatives. By knowing in advance who will be there, teams can prepare tailored conversations that align to therapeutic focus areas, investment stages, or partnership goals.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Teams targeting the life sciences and pharmaceutical sectors can gain traction at Pharma R&D 2026 by using the enriched conference attendee list to connect with key influencers in research, clinical trials, and digital health transformation.
Segment your outreach by company structure, such as global biopharma, mid-size biotech, CROs, or digital health innovators. Focus your messaging around current gaps in drug discovery, regulatory planning, and data infrastructure. Use attendee data to identify decision-makers responsible for R&D acceleration, pipeline expansion, and commercialization support.
Plan direct outreach to book meetings in advance with leaders overseeing therapeutic partnerships, clinical operations, or platform evaluations. These calendar slots fill quickly, and early connection increases the likelihood of meaningful discussions on site.
After the event, apply insights from your in-person conversations to send customized follow-ups that drive next steps. Whether it’s a proposal, platform demo, or pilot framework, context from the enriched attendee list makes that follow-up feel relevant and action-driven.
Timing Is Everything
Pharma R&D 2026 will take place on March 9, 2026. In a highly specialized environment like this, engaging early gives your organization a stronger position in front of the right stakeholders.
With Vendelux, your team can browse the enriched attendee list months in advance to see who matches your account strategy. Initiating conversations ahead of March means you’ll arrive with meetings confirmed, aligned to budget owners and technical leads who are already focused on partnerships or evaluations for 2026.
Align your conference planning, prioritization of outreach, and meeting scheduling with attendee list insights to maximize outcomes during and after the event.
What’s Included in the Pharma R&D 2026 Attendee List?
Vendelux provides visibility into executives expected to attend Pharma R&D 2026 through a combination of organizer-supplied data and predictive analytics. Clients can upload a list of target companies to detect which accounts are matched within the attendee list and direct their outreach strategies accordingly.
The enriched attendee list includes each participant’s first and last name, job title, company name, company website, location by city, state, and country, LinkedIn profile, verified email addresses, and phone numbers when available.
Where Is Pharma R&D 2026?
Pharma R&D 2026 will be held at the Four Points by Sheraton Wakefield Boston Hotel & Conference Center in Boston, Massachusetts, United States.
When Is Pharma R&D 2026?
Pharma R&D 2026 is scheduled for March 9, 2026.
What Type of Event Is Pharma R&D 2026?
Pharma R&D 2026 is a specialized life sciences event focused on drug discovery, clinical development, and regulatory pathways. The conference features executive panels, focused keynotes, and structured networking sessions designed to encourage knowledge exchange and partnership formation among pharma R&D leaders.
How Many People Attend Pharma R&D 2026?
Pharma R&D 2026 is expected to host around 300 participants, with representation from senior leaders across the pharmaceutical and biotechnology sectors. Attendees include executives in R&D, clinical operations, regulatory strategy, and external innovation, primarily from North America and Europe.
